A negative or very weakly positive DAT should not exclude investigation of drug-induced immune hemolytic anemia [2]

Transfusion

Volumn 43, Issue 11, 2003, Pages 1640-1641

  Leger, Regina M ^b   Arndt, Patricia A ^a   Garratty, George ^a  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTETAN; CEFTRIAXONE; DRUG ANTIBODY; PENICILLIN DERIVATIVE;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; ERYTHROCYTE TRANSFUSION; HUMAN; LETTER;

AGGLUTINATION TESTS; ANEMIA, HEMOLYTIC; ANTI-BACTERIAL AGENTS; CEFOTETAN; CEFTRIAXONE; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; HUMANS;

EID: 0242523641     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00562.x     Document Type: Letter

References (3)

1. Garratty G. Immune cytopenia associated with antibiotics. Transfus Med Rev 1993;7:255-67.
2. Arndt PA, Leger RM, Garratty G. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 1999;39:1239-46.
3. Garratty G, Leger RM, Arndt PA. Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures. Am J Obstet Gynecol 1999;181:103-4.